血管栓塞市場，依栓塞技術、應用、地理位置 - 規模、佔有率、前景和機會分析，2024 年 - 2031 年

Vascular Embolization Market, By Embolization Technique, By Application, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

出版日期: 2024年03月12日 | 出版商:

Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2024 年全球血管栓塞市場價值為 19.329 億美元，預計在預測期內（2024-2031 年）複合年成長率為 9.5%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	19.329 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	9.50%	2030/2031 價值預測：	36.482 億美元

2024 年全球血管栓塞市場價值（百萬美元），依地區分類

血管栓塞是指栓子在血流中的通過和滯留。它是一種微創治療，可阻塞一條或多條血管或異常血管通道。血管栓塞劑用於透過機械閉塞的方式急性阻止血管或血管區域的血流。這些藥劑經由導管釋放到血液中，以生物或機械方式閉塞目標血管；永久或暫時。血管栓塞劑的一些特徵是成功率高、很少使用麻醉劑、恢復時間更快、感染風險最小、無疤痕。栓塞是介入放射學中常見且有效的手術。它是開放性手術的替代方案。

市場動態：

臨床試驗數量的增加以及研發的增加預計將在預測期內促進全球血管栓塞市場的成長。例如，2021 年 3 月，Instylla Inc. 報告了第一批治療富血管腫瘤的關鍵 Embrace 水凝膠栓塞系統 (HES) 全球隨機臨床試驗的患者入組。

2022 年 3 月，Instylla 宣佈在《血管和介入放射學雜誌》(JVIR) 上發表 Embrace 水凝膠栓塞系統 (HES) 治療富血管腫瘤的首次人體臨床試驗結果。研究表明，HES 透過阻斷腫瘤血液供應，有效栓塞惡性和良性富血管腫瘤，技術上取得了成功，並且持續栓塞，如30 天影像追蹤中所指出的那樣，該研究治療的所有8 名患者均如此。

研究的主要特點：

該報告對全球血管栓塞市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數（例如公司亮點、產品組合、主要亮點、財務表現和策略）介紹了全球血管栓塞市場的主要參與者。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球血管栓塞市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
利害關係人可以透過用於分析全球血管栓塞市場的各種策略矩陣輕鬆做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 1,932.9 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	9.50%	2030/2031 Value Projection:	US$ 3,648.2 Mn

Vascular embolization refers to the passage and lodging of an embolus within the bloodstream. It is a minimally invasive treatment that blocks one or more blood vessels or abnormal vascular channels. Vascular embolization agents are used to acutely stop flow in blood vessel or vascular area by the means of mechanical occlusion. These agents are released into the blood through a catheter to biologically or mechanically occlude the target vessel; permanently or temporarily. High success rate, rare use of anesthetics, faster recovery time, minimal risk of infection, and no scarring are some features of vascular embolization agents. Embolization is a common and effective procedure in interventional radiology. It is an alternative to open surgery.

Market Dynamics:

Increasing number of clinical trials and increase in research and development is expected to augment the growth of the global vascular embolization market during the forecast period. For instance, in March 2021, Instylla Inc. reported the enrollment of the first patients in the pivotal Embrace Hydrogel Embolic System (HES) global randomized clinical trial for the treatment of hypervascular tumors.

In March 2022, Instylla announced the publication of results from the first-in-human clinical trial of Embrace Hydrogel Embolic System (HES) for the treatment of hypervascular tumors, in the Journal of Vascular and Interventional Radiology (JVIR). The study demonstrated that HES effectively embolized malignant & benign hypervascular tumors by blocking tumor blood supply with technical success and persistent embolization, as noted in imaging follow-up at 30-days, in all eight patients treated on this study.

Key features of the study:

This report provides in-depth analysis of the global vascular embolization market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global vascular embolization market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Shape Memory Medical Inc., Terumo Corp, Abbott Laboratories, Stryker Corporation, Cook Medical, Medtronic PLC, Merit Medical Systems Inc., Penumbra Inc., Johnson and Johnson (Cerenovus), and Boston Scientific Corporation, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global vascular embolization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular embolization market.

Detailed Segmentation:

Global Vascular Embolization Market, By Embolization Technique:
- Coiling Devices
- Non-coiling Devices
Global Vascular Embolization Market, By Application:
- Peripheral Vascular Disease
- Oncology
- Neurology
- Urology
- Other Applications
Global Vascular Embolization Market, By Geography:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Key Players Insights
- Shape Memory Medical Inc.
- Terumo Corp
- Penumbra Inc.
- Abbott Laboratories
- Stryker Corporation
- Cook Medical
- Medtronic PLC
- Merit Medical Systems Inc.
- Johnson and Johnson (Cerenovus)
- Boston Scientific Corporation

Market Dynamics
- Increasing prevalence of vascular diseases
- Complications associated with embolization procedures
- Increasing demand for vascular embolization devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Vascular Embolization Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Vascular Embolization Market, By Embolization Technique, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Coiling Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Non-coiling Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Vascular Embolization Market, By Application, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Peripheral Vascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Urology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Vascular Embolization Market, By Region, 2019-2031, (US$ Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
Rest of the World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)

8. Competitive Landscape

Shape Memory Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Penumbra Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stryker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cook Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merit Medical Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson and Johnson (Cerenovus)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies